Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Tenon Medical, Inc.TNON · Entity 2063 | Chief Financial Officer | December 31, 2023 | February 13, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Tenon Medical, Inc.
Report date December 31, 2023 · Filed February 13, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,565 |
Reported balance
After 2023-11-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-11-22 · Conversion · Acquired 1,522 · Balance 11,565 F1: These shares of common stock were issued pursuant to the vesting of Restricted Stock Units. F2: Includes 1,999 shares held by the Van Dick Family Trust-1998 for which Steve Van Dick is trustee. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,566 |
Reported balance
Holding disclosure · report date 2023-12-31 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 4,566 F3: Each Restricted Stock Unit represents the right to receive one share of Common Stock These units are on a 3 year vesting schedule, for the first year they vest on an annual basis and thereafter they vest on a semi-annual basis. 9,131 (post-split) Restricted Stock Units were initially granted on May 12, 2022. 4,565 Restricted Stock Units vested as of December 31, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares of common stock were issued pursuant to the vesting of Restricted Stock Units.
F2: Includes 1,999 shares held by the Van Dick Family Trust-1998 for which Steve Van Dick is trustee.
F3: Each Restricted Stock Unit represents the right to receive one share of Common Stock These units are on a 3 year vesting schedule, for the first year they vest on an annual basis and thereafter they vest on a semi-annual basis. 9,131 (post-split) Restricted Stock Units were initially granted on May 12, 2022. 4,565 Restricted Stock Units vested as of December 31, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 22, 2023 Filed Feb 13, 2024 16:48 UTC | Tenon Medical, Inc. TNON · Entity 2063 | ConversionCommon Stock | 1,522 | $2.02 | $3,074.44 |
DisclosureSEC source: 0001213900-24-013364 · ownership.xml · nonDerivative · entry 1 VAN DICK STEVEN M · CIK 0001369782 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,565 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These shares of common stock were issued pursuant to the vesting of Restricted Stock Units. F1 · shares: These shares of common stock were issued pursuant to the vesting of Restricted Stock Units. F2 · balance_after: Includes 1,999 shares held by the Van Dick Family Trust-1998 for which Steve Van Dick is trustee. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:36 UTC | Tenon Medical, Inc. TNON · Entity 2063 | PurchaseCommon Stock | 50,000 | $0.27 | $13,650.00 |
DisclosureSEC source: 0001213900-23-049214 · ownership.xml · nonDerivative · entry 1 VAN DICK STEVEN M · CIK 0001369782 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,416 F1 · balance_after: Includes 19,983 shares held by the Van Dick Family Trust-1998 for which Steven Van Dick is trustee. Read SEC document |
| May 22, 2023 Filed May 24, 2023 19:35 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Exercise / conversionCommon Stock | 30,433 | $1.62 | $49,301.46 |
DisclosureSEC source: 0001575872-23-000842 · ownership.xml · nonDerivative · entry 1 VAN DICK STEVEN M · CIK 0001369782 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These shares of common stock were issued pursuant to the vesting of Restricted Stock Units. F1 · kind: These shares of common stock were issued pursuant to the vesting of Restricted Stock Units. F2 · balance_after: Includes 19,983 shares held by the Van Dick Family Trust-1998 for which Steven Van Dick is trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.